AAPL 182.74 0.1864% MSFT 410.54 0.2932% GOOG 171.16 -1.0521% GOOGL 169.38 -1.092% AMZN 188.0 -0.4026% NVDA 904.12 -0.1568% META 472.6 0.9311% TSLA 174.72 -1.7378% TSM 143.6 1.7646% LLY 775.0 -0.3561% V 277.19 0.2641% AVGO 1325.37 1.7082% JPM 195.65 2.0339% UNH 503.21 0.4491% NVO 126.69 -0.4714% WMT 60.3 -0.5279% LVMUY 169.84 -0.2174% XOM 116.15 -0.0172% LVMHF 846.814 -0.7252% MA 454.77 0.3774%
Last update at 2024-01-23T20:02:01.870719Z
Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
Income before tax | -756.40300M | -542.25800M | -120.22700M | -81.61200M | -589.47700M |
Minority interest | - | - | - | - | - |
Net income | -749.93600M | -538.47800M | -100.07000M | -469.21900M | -422.21300M |
Selling general administrative | 4902.09M | 4998.76M | 4657.19M | 4587.34M | 4592.38M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 4803.94M | 5106.49M | 4704.32M | 4726.76M | 4676.35M |
Reconciled depreciation | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M |
Ebit | -98.14700M | 72.62M | 47.14M | 139.42M | 83.98M |
Ebitda | 178.44M | 368.31M | 374.26M | 467.70M | 441.86M |
Depreciation and amortization | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M |
Non operating income net other | 148.73M | -8.74000M | 117.00M | 55.69M | -0.55400M |
Operating income | -98.14700M | 72.62M | 47.14M | 139.42M | 83.98M |
Other operating expenses | 24190.05M | 24495.64M | 23996.10M | 21788.97M | 21555.58M |
Interest expense | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M |
Tax provision | -6.46700M | -3.78000M | -20.15700M | 387.61M | 77.48M |
Interest income | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M |
Net interest income | -224.39900M | -191.60100M | -201.38800M | -229.65700M | -227.72800M |
Extraordinary items | 0.00000M | 0.00000M | 9.16M | 17.05M | 244.74M |
Non recurring | 371.20M | 229.00M | 29.85M | - | -107.99400M |
Other items | - | - | - | - | - |
Income tax expense | -6.46700M | -3.78000M | -20.15700M | 387.61M | 77.48M |
Total revenue | 24091.90M | 24568.26M | 24043.24M | 21928.39M | 21639.56M |
Total operating expenses | 4902.09M | 5033.88M | 4657.19M | 4587.34M | 4592.38M |
Cost of revenue | 19287.96M | 19461.76M | 19338.92M | 17201.63M | 16963.21M |
Total other income expense net | -658.25600M | -614.87700M | -167.36400M | -221.03400M | -445.72600M |
Discontinued operations | - | - | 9.16M | 17.05M | 244.74M |
Net income from continuing ops | -749.93600M | -538.47800M | -100.07000M | -469.21900M | -666.95400M |
Net income applicable to common shares | -749.93600M | -538.47800M | -90.90900M | -452.17400M | -422.21300M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
Total assets | 7527.36M | 8529.00M | 9335.40M | 9452.37M | 7591.37M |
Intangible assets | 250.11M | 291.20M | 340.52M | 359.49M | 448.71M |
Earning assets | - | - | - | - | - |
Other current assets | 93.19M | 106.75M | 106.94M | 181.79M | 179.13M |
Total liab | 8169.14M | 8429.97M | 8720.25M | 8777.84M | 6404.68M |
Total stockholder equity | -641.77600M | 99.03M | 615.15M | 674.53M | 1186.69M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 724.53M | 780.63M | 642.36M | 37.06M | 727.73M |
Common stock | 56.63M | 55.75M | 55.14M | 54.72M | 1080.32M |
Capital stock | 56.63M | 55.75M | 55.14M | 54.72M | 54.02M |
Retained earnings | -6601.51700M | -5851.58100M | -5313.10300M | -5222.19400M | -4713.24400M |
Other liab | - | 151.98M | 208.21M | 204.44M | 482.89M |
Good will | 507.94M | 879.14M | 1108.14M | 1108.14M | 1108.14M |
Other assets | 63.29M | 106.61M | 139.96M | 157.99M | 624.29M |
Cash | 157.15M | 39.72M | 160.90M | 218.18M | 144.35M |
Cash and equivalents | 157.15M | 39.72M | 160.90M | 218.18M | 144.35M |
Total current liabilities | 2727.88M | 2933.09M | 2602.95M | 2766.46M | 2443.14M |
Current deferred revenue | - | - | - | 746.32M | 80.71M |
Net debt | 5662.36M | 5886.38M | 6271.35M | 6087.76M | 3350.41M |
Short term debt | 508.74M | 581.20M | 523.16M | 499.00M | 16.11M |
Short long term debt | 6.33M | 5.54M | 6.41M | 8.84M | 16.11M |
Short long term debt total | 5819.52M | 5926.10M | 6432.25M | 6305.94M | 3494.76M |
Other stockholder equity | 5917.96M | 5910.30M | 5897.17M | 5890.90M | 4850.67M |
Property plant equipment | 3404.98M | 3802.70M | 4144.58M | 1215.84M | 1308.51M |
Total current assets | 3301.05M | 3449.36M | 3595.17M | 3700.64M | 4101.72M |
Long term investments | - | - | - | - | - |
Net tangible assets | -1399.82400M | -1071.29900M | -833.50100M | -793.10000M | -370.15200M |
Short term investments | - | - | - | - | 7.19M |
Net receivables | 1149.96M | 1343.50M | 1462.44M | 1286.79M | 1788.71M |
Long term debt | 2925.26M | 2732.99M | 3063.09M | 3077.27M | 3454.59M |
Inventory | 1900.74M | 1959.39M | 1864.89M | 1921.60M | 1871.94M |
Accounts payable | 1494.61M | 1571.26M | 1437.42M | 1484.08M | 1618.59M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -14.85200M | -15.43700M | -24.05400M | -48.89800M | -31.05900M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 56.63M | 55.75M | 55.14M | 54.72M | 54.02M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | -6601.51700M | -5851.58100M | -5313.10300M | -5222.19400M | -4713.24400M |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 50.92M | 86.54M | 132.03M | 148.33M | 215.21M |
Deferred long term asset charges | - | - | - | - | 409.08M |
Non current assets total | 4226.31M | 5079.65M | 5740.23M | 5751.73M | 3489.65M |
Capital lease obligations | 2887.93M | 3187.57M | 3362.76M | 3219.83M | 24.06M |
Long term debt total | 2937.84M | 2747.82M | 3063.09M | 3077.27M | 3478.65M |
Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
Investments | -104.75900M | -134.07300M | -15.02500M | -86.54200M | 2.59M |
Change to liabilities | -207.59100M | 207.79M | -35.37200M | -154.23000M | -313.98100M |
Total cashflows from investing activities | -104.75900M | -134.07300M | -15.02500M | -149.84900M | -198.55200M |
Net borrowings | 277.29M | -363.79200M | -8.61900M | 600.00M | 803.41M |
Total cash from financing activities | 274.63M | -366.38000M | -65.24300M | -326.65200M | -540.50400M |
Change to operating activities | - | 72.92M | 1.98M | -86.40700M | -438.90600M |
Net income | -749.93600M | -538.47800M | -100.07000M | -469.21900M | -666.95400M |
Change in cash | 117.43M | -121.18100M | -57.27800M | 73.83M | -302.98100M |
Begin period cash flow | 39.72M | 160.90M | 218.18M | 144.35M | 447.33M |
End period cash flow | 157.15M | 39.72M | 160.90M | 218.18M | 144.35M |
Total cash from operating activities | -52.43900M | 379.27M | 22.99M | 487.02M | -228.66500M |
Issuance of capital stock | 0.00000M | 0.00000M | 0.05M | 0.00000M | 2.29M |
Depreciation | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M |
Other cashflows from investing activities | 110.53M | 86.64M | 284.70M | 63.31M | 660.38M |
Dividends paid | - | - | - | - | - |
Change to inventory | 5.16M | -97.11200M | 177.26M | 15.14M | -44.64500M |
Change to account receivables | 151.61M | 54.09M | -182.40400M | 486.56M | -75.84400M |
Sale purchase of stock | 0.00000M | 0.00000M | 0.05M | - | 2.29M |
Other cashflows from financing activities | 552.57M | 319.66M | 993.24M | 604.45M | -102.42800M |
Change to netincome | 294.74M | 245.40M | -174.69600M | 261.88M | 513.88M |
Capital expenditures | 247.69M | 220.71M | 224.94M | 214.39M | 244.69M |
Change receivables | 151.61M | 54.09M | -182.40400M | 486.56M | -75.84400M |
Cash flows other operating | -572.93900M | -326.56900M | 5.99M | -450.61500M | -665.95400M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | 117.43M | -121.18100M | -69.39900M | 34.36M | -302.98100M |
Change in working capital | -100.47800M | 169.12M | -38.52900M | 323.24M | -433.47000M |
Stock based compensation | 11.54M | 13.05M | 13.00M | 16.09M | 12.12M |
Other non cash items | 502.15M | 446.60M | -167.90500M | -97.26300M | 406.12M |
Free cash flow | -300.12400M | 158.56M | -201.95100M | 272.63M | -473.35400M |
Sector: Healthcare Industry: Pharmaceutical Retailers
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
RAD Rite Aid Corporation |
- -% | - | - | - | 0.0099 | 3.77 | 0.27 | -17.1507 |
WBA Walgreens Boots Alliance Inc |
-0.12 0.69% | 17.23 | - | 7.60 | 0.16 | 1.09 | 0.39 | -21.1795 |
RADLY Raia Drogasil SA ADR |
- -% | 5.00 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
ALBBY Alibaba Health Information Technology Limited |
-0.2038 2.52% | 7.89 | 63.53 | 135.14 | 0.27 | 3.41 | 0.19 | 5.91 |
ALBHF Alibaba Health Information Technology Limited |
- -% | 0.42 | 48.00 | 62.11 | 0.25 | 3.04 | 0.20 | 6.01 |
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
1200 Intrepid Avenue, Philadelphia, PA, United States
Name | Title | Year Born |
---|---|---|
Ms. Heyward Rutledge Donigan B.A. | Pres, CEO & Director | 1961 |
Mr. Matthew C. Schroeder | CFO & Exec. VP | 1970 |
Mr. Paul D. Gilbert | Exec. VP, Gen. Counsel & Corp. Sec. | 1967 |
Mr. Brian T. Hoover | Chief Accounting Officer & Sr. VP | 1965 |
Mr. Justin L. Mennen | Exec. VP and Chief Technology & Digital Officer | 1981 |
Byron Purcell | VP of Investor Relations & Treasurer | NA |
Joy Errico Seusing | Sr. VP & Chief Communications Officer | NA |
Mr. Frank G. Vitrano | Chief Strategic Bus. Devel. Officer | 1955 |
Ms. Jessica Kazmaier | Exec. VP & Chief HR Officer | 1978 |
Mr. Christopher S. Hall | Sr. VP of Pharmacy Services | 1965 |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).